OABI
OmniAbDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
OABI vs peer average
47/100
OABI vs. peer average (D vs. D)
Grade spread
A 1 · C 2 · D 4 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ABCL is the first available peer comparator.
AbCellera is the clearest public operating comparator because OmniAb names it as technical competition in both genetically engineered rodent discovery and single-cell screening, making it relevant for platform adoption, partner acquisition and discovery-tool differentiation [#10-K-2026-03-04].
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
OABI
OmniAb
ABCL
AbCellera Biologics
Grade
D
C
Momentum
87
92
Value
41
41
Sentiment
17
36
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs ABCL
OABI / ABCL
Grade Position
In line
OABI vs. peer average (D vs. D)
47/100
Momentum
87
ABCLValue
41
OABISentiment
17
ABCLRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs OABI
ABCL is the first peer returned for this comparison set.

